A significant difference in BRMS1 staining was observed between normal brain tissue and glioma tissue (P<0.01, χ2 test) and between tumor adjacent normal brain tissue and glioma tissue (P<0.01, χ2 test). The gene discussed is BRMS1; the disease is central nervous system cancer.